Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Olfactory deficit and hippocampal volume loss for early diagnosis of Alzheimer disease: a pilot study.

Marigliano V, Gualdi G, Servello A, Marigliano B, Volpe LD, Fioretti A, Pagliarella M, Valenti M, Masedu F, Di Biasi C, Ettorre E, Fusetti M.

Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):194-7. doi: 10.1097/WAD.0b013e31827bdb9f.

PMID:
23314063
2.

The brain structural and cognitive basis of odor identification deficits in mild cognitive impairment and Alzheimer's disease.

Kjelvik G, Saltvedt I, White LR, Stenumgård P, Sletvold O, Engedal K, Skåtun K, Lyngvær AK, Steffenach HA, Håberg AK.

BMC Neurol. 2014 Aug 26;14:168. doi: 10.1186/s12883-014-0168-1.

3.

Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment.

Vasavada MM, Wang J, Eslinger PJ, Gill DJ, Sun X, Karunanayaka P, Yang QX.

J Alzheimers Dis. 2015;45(3):947-58. doi: 10.3233/JAD-141947.

PMID:
25633674
4.

Follow-up study of olfactory deficits, cognitive functions, and volume loss of medial temporal lobe structures in patients with mild cognitive impairment.

Lojkowska W, Sawicka B, Gugala M, Sienkiewicz-Jarosz H, Bochynska A, Scinska A, Korkosz A, Lojek E, Ryglewicz D.

Curr Alzheimer Res. 2011 Sep;8(6):689-98.

PMID:
21592056
5.

Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease.

Devanand DP, Liu X, Tabert MH, Pradhaban G, Cuasay K, Bell K, de Leon MJ, Doty RL, Stern Y, Pelton GH.

Biol Psychiatry. 2008 Nov 15;64(10):871-9. doi: 10.1016/j.biopsych.2008.06.020. Epub 2008 Aug 23.

6.

Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer disease.

Mah L, Binns MA, Steffens DC; Alzheimer's Disease Neuroimaging Initiative..

Am J Geriatr Psychiatry. 2015 May;23(5):466-76. doi: 10.1016/j.jagp.2014.10.005. Epub 2014 Oct 29.

7.

Olfactory Dysfunction, Olfactory Bulb Volume and Alzheimer's Disease: Is There a Correlation? A Pilot Study1.

Servello A, Fioretti A, Gualdi G, Di Biasi C, Pittalis A, Sollaku S, Pavaci S, Tortorella F, Fusetti M, Valenti M, Masedu F, Cacciafesta M, Marigliano V, Ettorre E, Pagliarella M.

J Alzheimers Dis. 2015;48(2):395-402. doi: 10.3233/JAD-150232.

PMID:
26402003
8.

Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.

Devanand DP, Pradhaban G, Liu X, Khandji A, De Santi S, Segal S, Rusinek H, Pelton GH, Honig LS, Mayeux R, Stern Y, Tabert MH, de Leon MJ.

Neurology. 2007 Mar 13;68(11):828-36.

PMID:
17353470
9.

Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease.

Conti MZ, Vicini-Chilovi B, Riva M, Zanetti M, Liberini P, Padovani A, Rozzini L.

Arch Clin Neuropsychol. 2013 Aug;28(5):391-9. doi: 10.1093/arclin/act032. Epub 2013 May 12.

PMID:
23669447
10.

Awareness of olfactory deficits in healthy aging, amnestic mild cognitive impairment and Alzheimer's disease.

Bahar-Fuchs A, Moss S, Rowe C, Savage G.

Int Psychogeriatr. 2011 Sep;23(7):1097-106. doi: 10.1017/S1041610210002371. Epub 2011 Jan 21.

PMID:
21251352
11.

Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment.

Clerx L, van Rossum IA, Burns L, Knol DL, Scheltens P, Verhey F, Aalten P, Lapuerta P, van de Pol L, van Schijndel R, de Jong R, Barkhof F, Wolz R, Rueckert D, Bocchetta M, Tsolaki M, Nobili F, Wahlund LO, Minthon L, Frölich L, Hampel H, Soininen H, Visser PJ.

Neurobiol Aging. 2013 Aug;34(8):2003-13. doi: 10.1016/j.neurobiolaging.2013.02.002. Epub 2013 Mar 27.

12.

Amyloid-aβ Peptide in olfactory mucosa and mesenchymal stromal cells of mild cognitive impairment and Alzheimer's disease patients.

Ayala-Grosso CA, Pieruzzini R, Diaz-Solano D, Wittig O, Abrante L, Vargas L, Cardier J.

Brain Pathol. 2015 Mar;25(2):136-45. doi: 10.1111/bpa.12169. Epub 2014 Sep 5.

PMID:
25040401
13.

Can multi-modal neuroimaging evidence from hippocampus provide biomarkers for the progression of amnestic mild cognitive impairment?

Chen J, Zhang Z, Li S.

Neurosci Bull. 2015 Feb;31(1):128-40. doi: 10.1007/s12264-014-1490-8. Epub 2015 Jan 16. Review.

PMID:
25595368
14.

Olfactory identification in amnestic and non-amnestic mild cognitive impairment and its neuropsychological correlates.

Vyhnalek M, Magerova H, Andel R, Nikolai T, Kadlecova A, Laczo J, Hort J.

J Neurol Sci. 2015 Feb 15;349(1-2):179-84. doi: 10.1016/j.jns.2015.01.014. Epub 2015 Jan 14.

PMID:
25614440
15.

Accelerated hippocampal atrophy rates in stable and progressive amnestic mild cognitive impairment.

Wang PN, Liu HC, Lirng JF, Lin KN, Wu ZA.

Psychiatry Res. 2009 Mar 31;171(3):221-31. doi: 10.1016/j.pscychresns.2008.05.002. Epub 2009 Feb 13.

PMID:
19217759
16.

Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.

Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, Thompson PM.

Arch Neurol. 2006 May;63(5):693-9. Erratum in: Arch Neurol. 2007 Sep;64(9):1360-1.

PMID:
16682538
17.

Visual rating and volumetric measurement of medial temporal atrophy in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort: baseline diagnosis and the prediction of MCI outcome.

Varon D, Barker W, Loewenstein D, Greig M, Bohorquez A, Santos I, Shen Q, Harper M, Vallejo-Luces T, Duara R; Alzheimer's Disease Neuroimaging Initiative..

Int J Geriatr Psychiatry. 2015 Feb;30(2):192-200. doi: 10.1002/gps.4126. Epub 2014 May 12.

PMID:
24816477
18.

Correlation of hippocampal volume and cognitive performances in patients with either mild cognitive impairment or Alzheimer's disease.

Peng GP, Feng Z, He FP, Chen ZQ, Liu XY, Liu P, Luo BY.

CNS Neurosci Ther. 2015 Jan;21(1):15-22. doi: 10.1111/cns.12317. Epub 2014 Aug 21.

PMID:
25146658
19.

Left hippocampal volume loss in Alzheimer's disease is reflected in performance on odor identification: a structural MRI study.

Murphy C, Jernigan TL, Fennema-Notestine C.

J Int Neuropsychol Soc. 2003 Mar;9(3):459-71.

20.

Smell and preclinical Alzheimer disease: study of 29 patients with amnesic mild cognitive impairment.

Fusetti M, Fioretti AB, Silvagni F, Simaskou M, Sucapane P, Necozione S, Eibenstein A.

J Otolaryngol Head Neck Surg. 2010 Apr;39(2):175-81.

PMID:
20211105

Supplemental Content

Support Center